Skip to main content
Clinical Trials/NCT01181583
NCT01181583
Completed
N/A

Efficacy Testing of a Tailored Internet-delivered Cognitive Behaviour Therapy Treatment for Symptoms of Depression and Comorbid Problems

Linkoeping University1 site in 1 country121 target enrollmentAugust 13, 2010

Overview

Phase
N/A
Intervention
Not specified
Conditions
Depression
Sponsor
Linkoeping University
Enrollment
121
Locations
1
Primary Endpoint
Beck Depression Inventory (BDI)
Status
Completed
Last Updated
15 years ago

Overview

Brief Summary

The overall aim of this study is to develop and test a tailored Internet-delivered psychological treatment for patients with mild to moderate major depression and comorbid anxiety symptoms and compare its efficacy to a non-tailored treatment and to an active control group.

Detailed Description

Internet-delivered cognitive behaviour therapy (CBT) has emerged as a promising way to administer evidence-based psychological treatments. Mild to moderate major depression has previously been found to treatable via the Internet, with the provision that minimal therapist guidance is given. However, previous research has not taken the issue of comorbidity into account. It is well known that major depression often is accompanied by anxiety and in addition the symptom profile in major depression may differ substantially. The idea behind the proposed research is to tailor the Internet intervention according to the symptom profile. By used a large set of treatment modules (text-based) we aim to diagnose and then prescribe modules. In a randomized trial we want to compare this procedure (e.g., tailored CBT) with the standard Internet-delivered CBT. We will also include a control group in the form of a supervised online discussion group who will later receive CBT.

Registry
clinicaltrials.gov
Start Date
August 13, 2010
End Date
TBD
Last Updated
15 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Linkoeping University

Eligibility Criteria

Inclusion Criteria

  • Clinical diagnosis of Major Depressive Disorder
  • 15 or more on MADRS-S

Exclusion Criteria

  • Severe depression (more than 35 on MADRS-S or based on interview)
  • Severe psychiatric condition (e.g. psychosis or bipolar disorder)
  • Changed medication during the last three months

Outcomes

Primary Outcomes

Beck Depression Inventory (BDI)

Time Frame: 2 years after treatment ended

Secondary Outcomes

  • Montgomery Åsberg Depression Rating Scale Self-report (MADRS-S)(2 years after treatment ended)
  • Beck Anxiety Inventory (BAI)(2 years after treatment ended)
  • Quality of Life Inventory (QOLI)(2 years after treatment ended)

Study Sites (1)

Loading locations...

Similar Trials